At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 99 enrolled
Drug / intervention
Remifentanil R2 +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
"Hemodynamic Stability During Induction of General Anesthesia With Propofol and Remifentanil: A Randomized, Controlled, Double-blind Study Comparing Medium and Low Remifentanil Doses."
In Brief
A Phase 4 clinical trial evaluating Remifentanil R2, Remifentanil R4, and 1 other intervention for Hemodynamic Instability and 2 related conditions. Completed, enrolled 99 participants across 1 site.
Detailed Summary
In this trial the investigators want to examine if there is any difference in hemodynamic stability during induction when comparing two low and a medium remifentanil dose and keeping propofol induction dose at about 2.0 mg/kg.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesNorway
Collaborators--
Timeline
Phase 4CompletedFinished
20192020202120222023202420252026
First PostedMar 2019
Enrollment StartJun 2020
Primary CompletionFeb 2022
TodayJul 2026
First PostedMar 4, 2019
Enrollment StartJun 9, 2020
Primary CompletionFeb 2, 2022
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 7.3 years ago
Interventions
Remifentanil R2drug
0,7 microg/kg
Remifentanil R4drug
1,1 microg/kg
Remifentanil R8drug
1,7 microg/kg